A variable poly-T sequence modulates α-synuclein isoform expression and is associated with aging

Journal of Neuroscience Research

Volumn 85, Issue 7, 2007, Pages 1538-1546

  Beyer, Katrin ^a,e   Humbert, Jordi ^a   Ferrer, Anna ^a   Lao, José I ^b   Latorre, Pilar ^a   Lopez, Dolores ^a   Tolosa, Eduard ^c   Ferrer, Isidro ^d   Ariza, Aurelio ^a  

^a UNIVERSITAT AUTÒNOMA DE BARCELONA   (Spain)

^b Lab de Analisis Dr Echevarne   (Spain)

^c HOSPITAL CLÍNIC   (Spain)

^d HOSPITAL UNIVERSITARI DE BELLVITGE   (Spain)

^e HOSPITAL UNIVERSITARI GERMANS TRIAS I PUJOL   (Spain)

Author keywords

synuclein 126; synuclein polymorphism; Differential isoform expression; Mouse synuclein 126

Indexed keywords

ALPHA SYNUCLEIN; POLYTHYMIDYLIC ACID;

ADULT; AGED; AGING; ALZHEIMER DISEASE; ANIMAL TISSUE; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATIONAL STUDY; FEMALE; GENOTYPE; HUMAN; LEWY BODY; MALE; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN EXPRESSION; SEQUENCE ANALYSIS;

AGED; AGED, 80 AND OVER; AGING; ALPHA-SYNUCLEIN; ALZHEIMER DISEASE; ANIMALS; BASE SEQUENCE; CASE-CONTROL STUDIES; FEMALE; FRONTAL LOBE; GENE EXPRESSION REGULATION; GENE FREQUENCY; GENOTYPE; HUMANS; MALE; MICE; MICE, INBRED C57BL; MIDDLE AGED; MOLECULAR SEQUENCE DATA; PROTEIN ISOFORMS; REFERENCE VALUES; SEQUENCE HOMOLOGY; SPECIES SPECIFICITY;

EID: 34248162352     PISSN: 03604012     EISSN: 10974547     Source Type: Journal    
DOI: 10.1002/jnr.21270     Document Type: Article

References (36)

1. Atzmon G, Schechter C, Greiner W, Davidson D, Rennert G, Barzilai N. 2004. Clinical phenotype of families with longevity. J Am Geriatr Soc 52:274-277.
2. Bertoncini CW, Jung YS, Fernandez CO, Hoyer W, Griesinger C, Jovin TM, Zweckstetter M. 2005. Release of long-range tertiary interactions potentiates aggregation of natively unstructured α-synuclein. Proc Natl Acad Sci U S A 102:1430-1435.
3. Beyer K, Lao JI, Carrato C, Mate JL, Lopez D, Ferrer I, Ariza A. 2004. Differential expression of α-synuclein isoforms in dementia with Lewy bodies. Neuropathol Appl Neurobiol 30:601-607.
4. Beyer K, Humbert J, Ferrer A, Lao JI, Carrato C, López D, Ferrer I, Ariza A. 2006. Low α-synuclein 126 mRNA levels in dementia with Lewy bodies and Alzheimer disease. Neuroreport 17:1327-1330.
5. Blalock EM, Chen KC, Sharrow K, Herman JP, Porter NM, Foster TC, Landfield PW. 2003. Gene microarrays in hippocampal aging: statistical profiling identifies novel processes correlated with cognitive impairment. J Neurosci 23:3807-3819.
6. Bussell R Jr, Eliezer D. 2004. Effects of Parkinson's disease-linked mutations on the structure of lipid-associated α-synuclein. Biochemistry 43:4810-4818.
7. Cabin DE, Shimazu K, Murphy D, Cole NB, Gottschalk W, McIlwain KL, Orrison B, Chen A, Ellis CE, Paylor R, Lu B, Nussbaum RL. 2002. Synaptic vesicle depletion correlates with attenuated synaptic responses to prolonged repetitive stimulation in mice lacking α-synuclein. J Neurosci 22:8797-8807.
8. Campion D, Martin C, Heilig R, Charbonnier F, Moreau V, Flaman JM, Petit JL, Hannequin D, Brice A, Frebourg T. 1995. The NACP/ synuclein gene: chromosomal assignment and screening for alterations in Alzheimer disease. Genomics 26:254-257.
9. Cellini E, Nacmias B, Olivieri F, Ortenzi L, Tedde A, Bagnoli S, Petruzzi C, Franceschi C, Sorbi S. 2005. Cholesteryl ester transfer protein (CETP) I405V polymorphism and longevity in Italian centenarians. Mech Ageing Dev 126:826-828.
10. Chandra S, Chen X, Rizo J, Jahn R, Sudhof TC. 2003. A broken α-helix in folded α-synuclein. J Biol Chem 278:15313-15318.
11. Chu CS, Trapnell BC, Murtagh JJ Jr, Moss J, Dalemans W, Jallat S, Mercenier A, Pavirani A, Lecocq JP, Cutting GR, et al. 1991. Variable deletion of exon 9 coding sequences in cystic fibrosis transmembrane conductance regulator gene mRNA transcripts in normal bronchial epithelium. EMBO J 10:1355-1363.
12. Chu CS, Trapnell BC, Curristin S, Cutting GR, Crystal RG. 1993. Genetic basis of variable exon 9 skipping in cystic fibrosis transmembrane conductance regulator mRNA. Nat Genet 3:151-156.
13. Cuppens H, Lin W, Jaspers M, Costes B, Teng H, Vankeerberghen A, Jorissen M, Droogmans G, Reynaert I, Goossens M, Nilius B, Cassiman JJ. 1998. Polyvariant mutant cystic fibrosis transmembrane conductance regulator genes. The polymorphic (Tg)m locus explains the partial penetrance of the T5 polymorphism as a disease mutation. J Clin Invest 101:487-496.
14. Dalfo E, Barrachina M, Rosa JL, Ambrosio S, Ferrer I. 2004. Abnormal α-synuclein interactions with rab3a and rabphilin in diffuse Lewy body disease. Neurobiol Dis 16:92-97.
15. Davidson WS, Jonas A, Clayton DF, George JM. 1998. Stabilization of α-synuclein secondary structure upon binding to synthetic membranes. J Biol Chem 273:9443-9449.
16. Galvin JE, Ginsberg SD. 2005. Expression profiling in the aging brain: a perspective. Ageing Res Rev 4:529-547.
17. Giasson BI, Uryu K, Trojanowski JQ, Lee VM. 1999. Mutant and wild type human α-synucleins assemble into elongated filaments with distinct morphologies in vitro. J Biol Chem 274:7619-7622.
18. Hong L, Ko HW, Gwag BJ, Joe E, Lee S, Kim YT, Suh YH. 1998. The cDNA cloning and ontogeny of mouse α-synuclein. Neuroreport 9:1239-1243.
19. Iwai A, Masliah E, Yoshimoto M, Ge N, Flanagan L, de Silva HA, Kittel A, Saitoh T. 1995. The precursor protein of non-A beta component of Alzheimer's disease amyloid is a presynaptic protein of the central nervous system. Neuron 14:467-475.
20. Jao CC, Der-Sarkissian A, Chen J, Langen R. 2004. Structure of membrane-bound α-synuclein studied by site-directed spin labeling. Proc Nad Acad Sci U S A 101:8331-8336.
21. Kruger R, Kuhn W, Muller T, Woitalla D, Graeber M, Kosel S, Przuntek H, Epplen JT, Schols L, Riess O. 1998. Ala30Pro mutation in the gene encoding α-synuclein in Parkinson's disease. Nat Genet 18:106-108.
22. Kuusisto E, Parkkinen L, Alafuzoff I. 2003. Morphogenesis of Lewy bodies: dissimilar incorporation of α-synuclein, ubiquitin, and p62. J Neuropathol Exp Neurol 62:1241-1253.
23. Lee HJ, Choi C, Lee SJ. 2002. Membrane-bound α-synuclein has a high aggregation propensity and the ability to seed the aggregation of the cytosolic form. J Biol Chem 277:671-678.
24. Murphy DD, Rueter SM, Trojanowski JQ, Lee VM. 2000. Synucleins are developmentally expressed, and α-synuclein regulates the size of the presynaptic vesicular pool in primary hippocampal neurons. J Neurosci 20:3214-3220.
25. Perls T, Puca A. 2002. The genetics of aging - implications for pharmacogenomics. Pharmacogenomics 3:469-484.
26. Perls T, Terry D. 2003. Genetics of exceptional longevity. Exp Gerontol 38:725-730.
27. Perrin RJ, Woods WS, Clayton DF, George JM. 2000. Interaction of human α-synuclein and Parkinson's disease variants with phospholipids. Structural analysis using site-directed mutagenesis. J Biol Chem 275: 34393-34398.
28. Polymeropoulos MH, Lavedan C, Leroy E, Ide SE, Dehejia A, Dutra A, Pike B, Root H, Rubenstein J, Boyer R, Stenroos ES, Chandrasekharappa S, Athanassiadou A, Papapetropoulos T, Johnson WG, Lazzarini AM, Duvoisin RC, Di Iorio G, Golbe LI, Nussbaum RL. 1997. Mutation in the α-synuclein gene identified in families with Parkinson's disease. Science 276:2045-2047.
29. Preece P, Cairns NJ. 2003. Quantifying mRNA in postmortem human brain: influence of gender, age at death, postmortem interval, brain pH, agonal state and inter-lobe mRNA variance. Brain Res Mol Brain Res 118:60-71.
30. Preece P, Virley DJ, Costandi M, Coombes R, Moss SJ, Mudge AW, Jazin E, Cairns NJ. 2003. An optimistic view for quantifying mRNA in post-mortem human brain. Brain Res Mol Brain Res 116:7-16.
31. Schluter OM, Fornai F, Alessandri MG, Takamori S, Geppert M, Jahn R, Sudhof TC. 2003. Role of alpha-synuclein in 1-methyl-4-phenyl-1,2,3,6- tetrahydropyridine-induced parkinsonism in mice. Neuroscience 118:985-1002.
32. Spillantini MG, Crowther RA, Jakes R, Hasegawa M, Goedert M. 1998. α-Synuclein in filamentous inclusions of Lewy bodies from Parkinson's disease and dementia with lewy bodies. Proc Natl Acad Sci U S A 95:6469-6473.
33. Trojanowski JQ, Lee VM. 2003. Parkinson's disease and related α-synucleinopathies are brain amyloidoses. Ann N Y Acad Sci 991:107-110.
34. Ueda K, Fukushima H, Masliah E, Xia Y, Iwai A, Yoshimoto M, Otero DA, Kondo J, Ihara Y, Saitoh T. 1993. Molecular cloning of cDNA encoding an unrecognized component of amyloid in Alzheimer disease. Proc Natl Acad Sci U S A 90:11282-11286.
35. Ueda K, Saitoh T, Mori H. 1994. Tissue-dependent alternative splicing of mRNA for NACP, the precursor of non-A beta component of Alzheimer's disease amyloid. Biochem Biophys Res Commun 205:1366-1372.
36. Weinreb PH, Zhen W, Poon AW, Conway KA, Lansbury PT Jr. 1996. NACP, a protein implicated in Alzheimer's disease and learning, is natively unfolded. Biochemistry 35:13709-13715.